Cherington Charles

CIK 00014486983 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001448698

Recent Transactions

50 trades

Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2026-02-10$0.50/sh+4,000,000→ 6,779,440 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants to Purchase Common Stock
2026-02-10+4,000,000→ 4,000,000 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2025-06-09$0.10/sh+21,241,163→ 41,659,743 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2025-04-02$0.10/sh+3,768,397→ 20,401,602 total
Conversion
Ernexa Therapeutics Inc.$ERNA
12.0% Senior Convertible Notes due September 24, 2025
2024-10-29→ 0 total
Sale
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-10-29−2,475,524→ 0 total
Conversion
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-10-29$0.50/sh+2,819,546→ 16,628,123 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-10-29+1,562,988→ 13,808,577 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-10-29+5,420,823→ 12,245,589 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-10-29+4,768,783→ 5,587,004 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-10-29+261,756→ 818,221 total
Sale
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-10-29−523,512→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-10-29+1,237,762→ 6,824,766 total
Sale
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-10-29−3,125,976→ 0 total
Sale
Ernexa Therapeutics Inc.$ERNA
6.0% Senior Convertible Promissory Notes due 2028
2024-10-29→ 0 total
Sale
Ernexa Therapeutics Inc.$ERNA
12.0% Senior Convertible Notes due December 12, 2028
2024-10-29→ 0 total
Sale
Ernexa Therapeutics Inc.$ERNA
6.0% Senior Convertible Promissory Notes due 2028
2024-09-24→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
12.0% Senior Convertible Notes due September 24, 2025
2024-09-24$1368626.00/sh
Sale
Ernexa Therapeutics Inc.$ERNA
12.0% Senior Convertible Notes due December 12, 2028
2024-09-24→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-09-24+1,562,988→ 13,808,577 total
Sale
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-09-24−2,475,524→ 0 total
Sale
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-09-24−523,512→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-09-24+5,420,823→ 12,245,589 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-09-24+1,237,762→ 6,824,766 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-09-24+261,756→ 818,221 total
Sale
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-09-24−3,125,976→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2024-09-24+4,768,783→ 5,587,004 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-09-23+83,916→ 2,475,524 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2024-09-23+83,916→ 2,391,608 total
Purchase
Ernexa Therapeutics Inc.$ERNA
6.0% Senior Convertible Promissory Notes due 2028
2024-09-23
Purchase
Ernexa Therapeutics Inc.$ERNA
6.0% Senior Convertible Promissory Notes due 2028
2024-09-23
Purchase
Comera Life Sciences Holdings, Inc.
12.0% Senior Secured Convertible Notes
2023-12-29$567900.00/sh
Purchase
Comera Life Sciences Holdings, Inc.
Warrants to Purchase Common Stock
2023-12-29+20,650,908→ 20,650,908 total
Purchase
Comera Life Sciences Holdings, Inc.
Series A Convertible Perpetual Preferred Stock
2023-12-27$500000.00/sh+3,895.53→ 3,895.53 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2023-12-14$0.13/sh+3,125,976→ 3,125,976 total
Expiration (Short)
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2023-12-14−523,512→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2023-12-14+523,512→ 523,512 total
Expiration (Short)
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2023-12-14−2,307,692→ 0 total
Purchase
Ernexa Therapeutics Inc.$ERNA
12.0% Senior Convertible Notes
2023-12-14$3000000.00/sh
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2023-12-14+2,307,692→ 2,307,692 total
Purchase
Comera Life Sciences Holdings, Inc.
Common Stock
2023-09-11$0.51/sh+2,053,789→ 5,813,650 total
Purchase
Comera Life Sciences Holdings, Inc.
Warrants to Purchase Common Stock
2023-09-11+5,134,474→ 5,134,474 total
Purchase
Comera Life Sciences Holdings, Inc.
Common Stock
2023-07-31$0.51/sh+880,195→ 3,759,861 total
Purchase
Comera Life Sciences Holdings, Inc.
Warrants to Purchase Common Stock
2023-07-31+2,200,488→ 2,200,488 total
Purchase
Ernexa Therapeutics Inc.$ERNA
6.0% Senior Convertible Promissory Notes due 2028
2023-07-13$3300000.00/sh
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2023-07-13$0.13/sh+2,307,692→ 2,307,692 total
Purchase
Comera Life Sciences Holdings, Inc.
Warrants to Purchase Common Stock
2023-01-04$0.25/sh+743,243→ 743,243 total
Purchase
Comera Life Sciences Holdings, Inc.
Common Stock
2023-01-04$1.23/sh+743,243→ 2,879,666 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Common Stock
2022-12-02$3.28/sh+261,756→ 556,465 total
Purchase
Ernexa Therapeutics Inc.$ERNA
Warrants (right to buy)
2022-12-02$0.13/sh+523,512→ 523,512 total

Companies

Recent Filings

Address

200 BERKLEY STREET 26TH FLOOR

BOSTON, MA, 02116

View on SEC.gov